Miami, US-based Molekule Consulting has appointed Dr Daniel Pascheles as its new chief executive officer.
Dr Daniel Pascheles joins from Merck & Co, where he served as vice president and head of global competitive intelligence for the last 12 years.
While at Merck, Dr Pascheles provided strategy development, target and candidate identification for the firm’s licensing, business development and M&A activities, alongside leading the CI department.
Prior to this, Dr Pascheles worked at Aventis Pharmaceuticals – as well as its predecessor companies – for over 14 years, latterly as its vice president.
His previous roles include head of global competitive intelligence, global marketing director, general manager of Switzerland and European head of sales, marketing administration and strategic planning.
David Alderman, Molekule Consulting’s founder and president, said: “Dr Pascheles is one of the most experienced, ethical and well-respected CI professionals in our industry; he is a global leader who brings expertise and exceptional vision to build our growing company.”